Suzhou Abogen Biosciences Co., Ltd.

This study tests a personalized cancer vaccine (ABO2109) combined with an immunotherapy drug (toripalimab) in 50 adults with solid tumors who have already had surgery or other anti-cancer therapy. The goal is to see if the vaccine is safe and triggers an immune response against t…